Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Imaging the later-life white matter pathologies of repetitive head impacts: A novel pattern revealed through T2 FLAIR MRI

Authors
Jenna R Groh, Annalise E Miner, Mohamad J Alshikho, Chad Farris, Anna Cui, Erika Pettway, Jacob Labonte, Sydney Mosaheb, Yorghos Tripodis, Charles H Adler, Laura J Balcer, Charles Bernick, Robert C Cantu, Michael J Coleman, David W Dodick, Nicholas J Ashton, Henrik Zetterberg, Kaj Blennow, Elaine R Peskind, Christopher Nowinski, Monica Ly, Caroline Altaras, Steven Lenio, Gil D Rabinovici, Breton Asken, Howard Rosen, Yann Cobigo, Jan Krzysztof Blusztajn, Andrew E Budson, Katherine Turk, Wei Qiao Qiu, Lee Goldstein, Brett Martin, Joseph N Palmisano, Diane Dixon, Greta Schneider, Eric G Steinberg, Yi Su, Hillary Protas, Ofer Pasternak, Inga Koerte, Sylvain Bouix, Jeffrey L Cummings, Eric M Reiman, Martha E Shenton, Robert A Stern, Ann C McKee, Thor D Stein, Adam M Brickman, Jesse Mez, Michael L Alosco
Imaging the later-life white matter pathologies of repetitive head impacts: A novel pattern revealed through T2 FLAIR MRI
The journal of prevention of Alzheimer's disease
Published

Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data

Authors
Bjoern O Schelter, Helen Shiells, Serena Lo, Nafeesa Nazlee, Emily Evans, Peter Bentham, Serge Gauthier, Henrik Zetterberg, Gordon K Wilcock, Lutz Froelich, Alistair Burns, Emer MacSweeney, Clive Ballard, Jin-Tai Yu, Tay Siew Choon, Vahe Asvatourian, Natalia Muehlemann, Jan Priel, Karin Kook, Tenecia Sullivan, Diane Downie, Sonya Miller, Carol Pringle, John M D Storey, Tom Baddeley, Charles R Harrington, Roger Staff, Anca-Larisa Sandu, Claire Hull, Richard Stefanacci, Claude M Wischik, Alzheimer's Disease Neuroimaging Initiative
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Associations of <sup>18</sup>F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum

Authors
Mahnaz Shekari, Armand González Escalante, Marta Milà-Alomà, Carles Falcon, David López-Martos, Gonzalo Sánchez-Benavides, Anna Brugulat-Serrat, Aida Niñerola-Baizán, Nicholas J Ashton, Thomas K Karikari, Juan Lantero-Rodriguez, Laia Montoliu-Gaya, Anniina Snellman, Theresa A Day, Jeffrey L Dage, Paula Ortiz-Romero, Matteo Tonietto, Edilio Borroni, Gregory Klein, Gwendlyn Kollmorgen, Margherita Carboni, Clara Quijano-Rubio, Eugeen Vanmechelen, Carolina Minguillón, Karine Fauria, Andrés Perissinotti, José Luis Molinuevo, Henrik Zetterberg, Kaj Blennow, Oriol Grau-Rivera, Marc Suárez-Calvet, Juan Domingo Gispert, ALFA Study
Associations of <sup>18</sup>F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia

Zetterberg Lab